Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Thesis
  • Published:

The need for rules and regulations

Nature Nanotechnology volume 2, pages 333–334 (2007)Cite this article

Nanotechnology could have an enormous impact on medicine but, says Michael Helmus, the regulations that govern new drugs and medical devices need to be updated before nanomedicine can be commercialized.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Nanomaterials for medical therapies can be categorized as nanoporous, nanostructured, nanoparticles and nanocomposites.

Author information

Authors and Affiliations

  1. Michael N. Helmus is senior vice president for Biopharma at Advance Nanotech. michael.helmus@Advancenanotech.com,

    Michael N. Helmus

Authors
  1. Michael N. Helmus
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Helmus, M. The need for rules and regulations. Nature Nanotech 2, 333–334 (2007). https://doi.org/10.1038/nnano.2007.165

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1038/nnano.2007.165

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing